Pablo G. Legorreta - Dec 30, 2022 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Pablo G. Legorreta
Stock symbol
RPRX
Transactions as of
Dec 30, 2022
Transactions value $
$0
Form type
4
Date filed
11/16/2023, 05:50 PM
Previous filing
Aug 16, 2022
Next filing
Feb 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A ordinary shares Gift $0 +292K $0.00 292K Dec 30, 2022 By Tata MC 35 Ltd.
transaction RPRX Class A ordinary shares Other $0 -383K -85.72% $0.00 63.8K Nov 16, 2023 Direct F1, F2
holding RPRX Class A ordinary shares 600K Dec 30, 2022 By Legorreta 2023 SR Trust
holding RPRX Class A ordinary shares 460K Dec 30, 2022 By Legorreta Investments LLC
holding RPRX Class A ordinary shares 902K Dec 30, 2022 By GST-Exempt Legorreta 2012 Family Trust
holding RPRX Class A ordinary shares 41.3K Dec 30, 2022 By GST-Exempt Legorreta 2020 Family Trust
holding RPRX Class A ordinary shares 10K Dec 30, 2022 By Child
holding RPRX Class A ordinary shares 10K Dec 30, 2022 By Child
holding RPRX Class A ordinary shares 123K Dec 30, 2022 By IRRA
holding RPRX Class A ordinary shares 119K Dec 30, 2022 By SEP/IRA
holding RPRX Class A ordinary shares 1.04M Dec 30, 2022 By Legorreta Children 2002 Trust
holding RPRX Class A ordinary shares 6.93K Dec 30, 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the transfer by the Reporting Person of Class A ordinary shares for no consideration to RP Management Equity Incentive Plan Trust.
F2 Reflects the exempt transfer pursuant to Rule 16a-13 of Class A ordinary shares from the GST-Exempt Legorreta 2012 Family Trust.